Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Mar 3;13(3):265.
doi: 10.3390/vaccines13030265.

New Trends in SARS-CoV-2 Variants and Vaccines

Seik-Soon Khor  1
Affiliations
Editorial

New Trends in SARS-CoV-2 Variants and Vaccines

Seik-Soon Khor. Vaccines (Basel). .

Abstract

The COVID-19 pandemic has significantly impacted global health, with the continued emergence of new SARS-CoV-2 variants presenting substantial challenges in terms of both vaccine efficacy and public health strategies [...].

PubMed Disclaimer

Conflict of interest statement

No conflicts of interest were reported by the author.

References

    1. Gerardi V., Rohaim M.A., Naggar R.F.E., Atasoy M.O., Munir M. Deep Structural Analysis of Myriads of Omicron Sub-Variants Revealed Hotspot for Vaccine Escape Immunity. Vaccines. 2023;11:668. doi: 10.3390/vaccines11030668. - DOI - PMC - PubMed
    1. Olukitibi T.A., Ao Z., Warner B., Unat R., Kobasa D., Yao X. Significance of Conserved Regions in Coronavirus Spike Protein for Developing a Novel Vaccine against SARS-CoV-2 Infection. Vaccines. 2023;11:545. doi: 10.3390/vaccines11030545. - DOI - PMC - PubMed
    1. Zhang L., Dopfer-Jablonka A., Nehlmeier I., Kempf A., Graichen L., Calderón Hampel N., Cossmann A., Stankov M.V., Morillas Ramos G., Schulz S.R., et al. Virological Traits of the SARS-CoV-2 BA.2.87.1 Lineage. Vaccines. 2024;12:487. doi: 10.3390/vaccines12050487. - DOI - PMC - PubMed
    1. Meurisse M., Catteau L., van Loenhout J.A.F., Braeye T., De Mot L., Serrien B., Blot K., Cauët E., Van Oyen H., Cuypers L., et al. Homologous and Heterologous Prime-Boost Vaccination: Impact on Clinical Severity of SARS-CoV-2 Omicron Infection among Hospitalized COVID-19 Patients in Belgium. Vaccines. 2023;11:378. doi: 10.3390/vaccines11020378. - DOI - PMC - PubMed
    1. Ouyang M.J., Ao Z., Olukitibi T.A., Lawrynuik P., Shieh C., Kung S.K.P., Fowke K.R., Kobasa D., Yao X. Oral Immunization with rVSV Bivalent Vaccine Elicits Protective Immune Responses, Including ADCC, against Both SARS-CoV-2 and Influenza A Viruses. Vaccines. 2023;11:1404. doi: 10.3390/vaccines11091404. - DOI - PMC - PubMed

Publication types

LinkOut - more resources